Antipsychotic-associated all-cause and cardiac mortality: what should we worry about and how should the risk be assessed?

Acta Psychiatr Scand. 2010 Nov;122(5):341-4. doi: 10.1111/j.1600-0447.2010.01610.x.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Data Interpretation, Statistical
  • Heart Diseases / chemically induced
  • Heart Diseases / mortality*
  • Humans
  • Imidazoles / adverse effects
  • Imidazoles / therapeutic use
  • Indoles / adverse effects
  • Indoles / therapeutic use
  • Randomized Controlled Trials as Topic / standards
  • Risk Factors
  • Risperidone / adverse effects
  • Risperidone / therapeutic use
  • Schizophrenia / drug therapy
  • Schizophrenia / mortality

Substances

  • Antipsychotic Agents
  • Imidazoles
  • Indoles
  • sertindole
  • Risperidone